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Sixteen exons across the EXT2 locus were identified, 
two of which (1a and 1b) are alternatively spliced; 
spans approximately 108 kb of genomic DNA. 
Transcription 
3.5 and 3.7 kb. 
Protein 
Description 
718 amino acids; 82.2 kDa. 
Expression 




A tumour suppressor function is suggested; EXT2 is a 
glycosyltransferase, suggested to be involved in chain 
polymerization of heparan sulphate. 
Homology 




Germline mutations in EXT2 are causative for 
hereditary multiple exostoses, a heterogeneous 
autosomal dominant disorder; mutations include 
nucleotide substitutions (57%), small deletions (19%) 
and small insertions (24%), of which the majority is 
predicted to result in a truncated or non-functional 
protein. 
Somatic 
No somatic mutations were found in 34 sporadic and 
hereditary osteochondromas and secondary peripheral 
chondrosarcomas tested. 
Implicated in 
Hereditary multiple exostoses 
Prognosis 
The main complication in hereditary multiple exostoses 
is malignant transformation of an osteochondroma 
(exostosis) into chondrosarcoma, which is estimated to 
occur in 1-5% of the HME cases. 
Cytogenetics 
11p rearrangement was found in 1 sporadic 
osteochondroma (exostosis) using cytogenetic analysis; 
loss of heterozygosity at the EXT2 locus was absent in 
14 osteochondromas. 
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